Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001929354-23-000012)

Filing Details

Accession Number:: 0001929354-23-000012
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-06-02 16:22:32
Reporting Period:: 2023-05-31

Accepted Time:: 2023-06-02 16:22:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1534120	Avalo Therapeutics Inc.	AVTX	Pharmaceutical Preparations (2834)	450705648

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1929354	Ltd. Management Capital Caissa	Palm Grove House Wickhams Cay 1 Road Town Tortola D8 VG1110		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-05-31	844	$2.87	1,386,215	No	4	P	Indirect	See Footnote (1)

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote (1)

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	182,300	Direct

Footnotes

Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
These shares are directly owned by Mr. Golestaneh in his personal capacity.